Issues with the patent linkage system in Mexico

More than 20 years ago the Decree Reforming the Regulation of Supplies for Health and the Regulation of the Industrial Property Law was published in Mexico.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

Patent Linkage-2021 Developments and Their Impact on the Generics and Biosimilar Landscape

9 December 2021 Patent linkage is a complex issue as it amalgamates the protection of IP with the remit of drug regulators in varying jurisdictions. The scope of this interaction varies in different countries and pharmaceutical companies need to know which jurisdictions adopt a patent linkage regime when they decide whether to adopt an enforcement strategy or seek regulatory approval for a new product.

Asia

China accepts cluster of complaints under new patent linkage law

9 November 2021 The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Trump’s march-in rights threat: Why pharma is rethinking collaborations

GSK escalates mRNA COVID-19 vaccine dispute

Smart ringleader: Could Ōura’s market dominance be under threat?

Roche resolves cancer test dispute with Stanford affiliated startup

Issues with the patent linkage system in Mexico

More on this story

Editor's picks

Editor's picks

More features